Omega-3 fatty acids status in human subjects estimated using a food frequency questionnaire and plasma phospholipids levels

Nutrition Journal

Volumn 11, Issue 1, 2012, Pages

  Garneau, Véronique ^a,b,c   Rudkowska, Iwona ^a,b,c   Paradis, Ann Marie ^a,b,c   Godin, Gaston ^a   Julien, Pierre ^b   Pérusse, Louis ^a,b,c   Vohl, Marie Claude ^a,b,c  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Biomarker; Food frequency questionnaire; Gas chromatography; n 3 PUFA; Plasma phospholipids

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID;

ADULT; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DIETARY INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GAS CHROMATOGRAPHY; HUMAN; LIPID COMPOSITION; MALE; PHOSPHOLIPID BLOOD LEVEL; SEX DIFFERENCE;

ADOLESCENT; ADULT; ALPHA-LINOLENIC ACID; CANADA; CHROMATOGRAPHY, GAS; DIET; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, UNSATURATED; FEMALE; FOOD HABITS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PHOSPHOLIPIDS; QUESTIONNAIRES; YOUNG ADULT;

EID: 84863521898     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-11-46     Document Type: Article

References (53)

1. Omega-3 fatty acids: a comprehensive review of their role in health and disease. Yashodhara BM, Umakanth S, Pappachan JM, Bhat SK, Kamath R, Choo BH, Postgrad Med J 2009 85 84 90 10.1136/pgmj.2008.073338 19329703
2. Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome. Robinson LE, Buchholz AC, Mazurak VC, Appl Physiol Nutr Metab 2007 32 1008 1024 10.1139/H07-087 18059573
3. n-3 fatty acids and the metabolic syndrome. Carpentier YA, Portois L, Malaisse WJ, Am J Clin Nutr 2006 83 1499S 1504S 16841860 (Pubitemid 44713091)
4. Fatty acids and the metabolic syndrome. Roche HM, Proc Nutr Soc 2005 64 23 29 10.1079/PNS2004405 15877919 (Pubitemid 40685748)
5. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY, Clin Chem 2006 52 2265 2272 10.1373/clinchem.2006.072322 17053155 (Pubitemid 44925001)
6. New evidence for the cardiovascular benefits of long chain omega-3 fatty acids. Hansen SN, Harris WS, Curr Atheroscler Rep 2007 9 434 440 10.1007/s11883-007-0058-8 18377782
7. Cardiovascular risk and the omega-3 index. von SC, Harris WS, J Cardiovasc Med (Hagerstown) 2007 8 Suppl 1 46 S49 10.2459/01.JCM.0000289273. 87803.87 (Pubitemid 47429083)
8. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Massaro M, Scoditti E, Carluccio MA, De CR, Prostaglandins Leukot Essent Fatty Acids 2008 79 109 115 10.1016/j.plefa.2008.09.009 18951002
9. Omega-3 fatty acids and major depression: a primer for the mental health professional. Logan AC, Lipids Health Dis 2004 3 25 10.1186/1476-511X-3-25 15535884 (Pubitemid 40117657)
10. Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Micallef M, Munro I, Phang M, Garg M, Br J Nutr 2009 102 1370 1374 10.1017/S0007114509382173 19454127
11. A diet rich in long chain omega-3 fatty acids modulates satiety in overweight and obese volunteers during weight loss. Parra D, Ramel A, Bandarra N, Kiely M, Martinez JA, Thorsdottir I, Appetite 2008 51 676 680 10.1016/j.appet.2008.06.003 18602429
12. Long-chain n-3 fatty acids enhance neonatal insulin-regulated protein metabolism in piglets by differentially altering muscle lipid composition. Bergeron K, Julien P, Davis TA, Myre A, Thivierge MC, J Lipid Res 2007 48 2396 2410 10.1194/jlr.M700166-JLR200 17673528 (Pubitemid 350058751)
13. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Calder PC, Mol Nutr Food Res 2008 52 885 897 10.1002/mnfr.200700289 18504706
14. Development, validation and utilisation of food-frequency questionnaires-a review. Cade J, Thompson R, Burley V, Warm D, Public Health Nutr 2002 5 567 587 10.1079/PHN2001318 12186666
15. Dietary assessment methods on n-3 fatty acid intake: a systematic review. Overby NC, Serra-Majem L, Andersen LF, Br J Nutr 2009 102 Suppl 1 56 S63 20100368
16. Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women. Goulet J, Nadeau G, Lapointe A, Lamarche B, Lemieux S, Nutr J 2004 3 13 10.1186/1475-2891-3-13 15363100
17. Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European Prospective Investigation into cancer and nutrition. Saadatian-Elahi M, Slimani N, Chajes V, Jenab M, Goudable J, Biessy C, et al. Am J Clin Nutr 2009 89 331 346 19056549
18. The use of fatty acid biomarkers to reflect dietary intake. Baylin A, Campos H, Curr Opin Lipidol 2006 17 22 27 10.1097/01.mol.0000199814.46720.83 16407712 (Pubitemid 43100299)
19. Biomarkers of fat and fatty acid intake. Arab L, J Nutr 2003 133 Suppl 3 925S 932S 12612178 (Pubitemid 36262800)
20. Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL, Am J Clin Nutr 2004 80 1167 1174 15531662 (Pubitemid 41350675)
21. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Hodson L, Skeaff CM, Fielding BA, Prog Lipid Res 2008 47 348 380 10.1016/j.plipres.2008.03.003 18435934
22. Validity of a self-reported measure of familial history of obesity. Paradis AM, Perusse L, Godin G, Vohl MC, Nutr J 2008 7 27 10.1186/1475-2891-7-27 18783616
23. Le mode alimentaire méditerranéen chez des femmes québécoises en santé: applicabilité et effets sur la santé Goulet J, These.Département des sciences des aliments et de nutrition.Faculté des sciences de l'agriculture et de l'alimentation Université Laval, Québec 2007 318 319
24. The omega-3 index as a risk factor for coronary heart disease. Harris WS, Am J Clin Nutr 2008 87 1997S 2002S 18541601 (Pubitemid 351872681)
25. Omega-3 fatty acids and risk of dementia: the Canadian study of health and aging. Kroger E, Verreault R, Carmichael PH, Lindsay J, Julien P, Dewailly E, et al. Am J Clin Nutr 2009 90 184 192 10.3945/ajcn.2008.26987 19474137
26. Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB, Designing Clinical Research- An Epidemiologic Approach Second 2001 85
27. Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohort. Hodge AM, Simpson JA, Gibson RA, Sinclair AJ, Makrides M, O'Dea K, et al. Nutr Metab Cardiovasc Dis 2007 17 415 426 10.1016/j.numecd.2006.04.005 16962297 (Pubitemid 47071964)
28. Validity of estimated dietary eicosapentaenoic acid and docosahexaenoic acid intakes determined by interviewer-administered food frequency questionnaire among older adults with mild-to-moderate cognitive impairment or dementia. Arsenault LN, Matthan N, Scott TM, Dallal G, Lichtenstein AH, Folstein MF, et al. Am J Epidemiol 2009 170 95 103 10.1093/aje/kwp089 19433614
29. Dietary validation of a new Australian food-frequency questionnaire that estimates long-chain n-3 polyunsaturated fatty acids. Sullivan BL, Brown J, Williams PG, Meyer BJ, Br J Nutr 2008 99 660 666 17903342 (Pubitemid 351223435)
30. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Hodge AM, English DR, O'Dea K, Sinclair AJ, Makrides M, Gibson RA, et al. Am J Clin Nutr 2007 86 189 197 17616780 (Pubitemid 47041610)
31. Validity and reliability of a quantitative food frequency questionnaire measuring n-3 fatty acid intakes in cardiac patients in the Midwest: a validation pilot study. Ritter-Gooder PK, Lewis NM, Heidal KB, Eskridge KM, J Am Diet Assoc 2006 106 1251 1255 10.1016/j.jada.2006.05.005 16863722 (Pubitemid 44079964)
32. Validation of a FFQ to estimate the intake of PUFA using plasma phospholipid fatty acids and weighed foods records. McNaughton SA, Hughes MC, Marks GC, Br J Nutr 2007 97 561 568 10.1017/S0007114507381385 17313719 (Pubitemid 46662047)
33. Validity and reproducibility of a food frequency questionnaire for pregnant Finnish women. Erkkola M, Karppinen M, Javanainen J, Rasanen L, Knip M, Virtanen SM, Am J Epidemiol 2001 154 466 476 10.1093/aje/154.5.466 11532789 (Pubitemid 32845485)
34. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM, Am J Clin Nutr 2006 83 1526S 1535S 16841863 (Pubitemid 44713094)
35. Rapid declines in coronary heart disease mortality in Eastern Europe are associated with increased consumption of oils rich in alpha-linolenic acid. Zatonski W, Campos H, Willett W, Eur J Epidemiol 2008 23 3 10 10.1007/s10654-007-9195-1 17955332
36. Dietary reference intakes for DHA and EPA. Kris-Etherton PM, Grieger JA, Etherton TD, Prostaglandins Leukot Essent Fatty Acids 2009 81 99 104 10.1016/j.plefa.2009.05.011 19525100
37. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Harris WS, Kris-Etherton PM, Harris KA, Curr Atheroscler Rep 2008 10 503 509 10.1007/s11883-008-0078-z 18937898
38. n-3 Fatty acid intake from marine food products among Quebecers: comparison to worldwide recommendations. Lucas M, Asselin G, Plourde M, Cunnane SC, Dewailly E, Dodin S, Public Health Nutr 2010 13 63 70 10.1017/ S1368980009005679 19433004
39. Dietary intake of fats and fatty acids for the United States population: 1999-2000. Ervin RB, Wright JD, Wang CY, Kennedy-Stephenson J, Adv Data 2004 348 1 6 15587902
40. Dietary intake of long-chain omega-3 polyunsaturated fatty acids: contribution of meat sources. Howe P, Meyer B, Record S, Baghurst K, Nutrition 2006 22 47 53 10.1016/j.nut.2005.05.009 16289978 (Pubitemid 43175784)
41. Dietary fish intake and plasma phospholipid n-3 polyunsaturated fatty acid concentrations in men and women in the European prospective investigation into cancer-Norfolk United Kingdom cohort. Welch AA, Bingham SA, Ive J, Friesen MD, Wareham NJ, Riboli E, et al. Am J Clin Nutr 2006 84 1330 1339 17158413 (Pubitemid 44912814)
42. Reliability of fatty acid composition in human serum phospholipids. Zeleniuch-Jacquotte A, Chajes V, Van Kappel AL, Riboli E, Toniolo P, Eur J Clin Nutr 2000 54 367 372 10.1038/sj.ejcn.1600964 10822282 (Pubitemid 30261386)
43. Biomarker validation of a long-chain omega-3 polyunsaturated fatty acid food frequency questionnaire. Sullivan BL, Williams PG, Meyer BJ, Lipids 2006 41 845 850 10.1007/s11745-006-5039-0 17152921 (Pubitemid 44788905)
44. Validation of a food frequency questionnaire measurement of selected nutrients using biological markers in African-American men. Holmes MD, Powell IJ, Campos H, Stampfer MJ, Giovannucci EL, Willett WC, Eur J Clin Nutr 2007 61 1328 1336 10.1038/sj.ejcn.1602641 17299490 (Pubitemid 350048216)
45. Calibration of a semi-quantitative food frequency questionnaire in early pregnancy. Fawzi WW, Rifas-Shiman SL, Rich-Edwards JW, Willett WC, Gillman MW, Ann Epidemiol 2004 14 754 762 10.1016/j.annepidem.2004.03.001 15519898 (Pubitemid 39446397)
46. Plasma n-6 and n-3 polyunsaturated fatty acids as biomarkers of their dietary intakes: a cross-sectional study within a cohort of middle-aged French men and women. Astorg P, Bertrais S, Laporte F, Arnault N, Estaquio C, Galan P, et al. Eur J Clin Nutr 2008 62 1155 1161 10.1038/sj.ejcn.1602836 17622261
47. Validation of a food frequency questionnaire to assess intake of n-3 polyunsaturated fatty acids in subjects with and without major depressive disorder. Sublette ME, Segal-Isaacson CJ, Cooper TB, Fekri S, Vanegas N, Galfalvy HC, et al. J Am Diet Assoc 2011 111 117 123 10.1016/j.jada.2010.10.007 21185973
48. A valid semiquantitative food frequency questionnaire to measure fish consumption. Mina K, Fritschi L, Knuiman M, Eur J Clin Nutr 2007 61 1023 1031 10.1038/sj.ejcn.1602617 17299496 (Pubitemid 47207748)
49. Relative validity and reproducibility of a 14-item semi-quantitative food frequency questionnaire for cardiovascular prevention. Laviolle B, Froger-Bompas C, Guillo P, Sevestre A, Letellier C, Pouchard M, et al. Eur J Cardiovasc Prev Rehabil 2005 12 587 595 16319550 (Pubitemid 44972989)
50. Erythrocyte cell membrane phospholipid levels compared against reported dietary intakes of polyunsaturated fatty acids in pregnant Mexican women. Parra MS, Schnaas L, Meydani M, Perroni E, Martinez S, Romieu I, Public Health Nutr 2002 5 931 937 10.1079/PHN2002381 12633518 (Pubitemid 36313640)
51. Essential Fatty acids-a review. Das UN, Curr Pharm Biotechnol 2006 7 467 482 10.2174/138920106779116856 17168664 (Pubitemid 46017539)
52. Relationship between n-3 and n-6 plasma fatty acid levels and insulin resistance in coronary patients with and without metabolic syndrome. Nigam A, Frasure-Smith N, Lesperance F, Julien P, Nutr Metab Cardiovasc Dis 2009 19 264 270 10.1016/j.numecd.2008.07.008 18804984
53. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M, J Lipid Res 1997 38 2012 2022 9374124 (Pubitemid 27468010)